Tazemetostat Hydrobromide
CAS 1557520-12-0Small Molecule
Overview
Tazemetostat Hydrobromide is a small molecule inhibitor of the EZH2 methyltransferase, which is involved in the regulation of gene expression through histone modification. It is primarily used in the treatment of certain types of cancers, including epithelioid sarcoma.
Therapeutic areas
Oncology
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.